title: In search of preclinical robustness.
abstract: Systematic engagement of statisticians in preclinical research could help address the weaknesses that are undermining the likelihood of subsequent success in drug discovery and development.
authors.affiliation: AstraZeneca 13F41 Mereside, Alderley Park, Macclesfield SK10 4TG, UK. Ian.Peers@astrazeneca.com
authors.forename: Ian S
authors.initials: IS
authors.lastname: Peers
authors.forename: Peter R
authors.initials: PR
authors.lastname: Ceuppens
authors.forename: Chris
authors.initials: C
authors.lastname: Harbron
mesh_terms: D000818:Animals; D035843:Biomedical Research / Q000379:methods / Q000706:statistics & numerical data; D055808:Drug Discovery / Q000379:methods / Q000706:statistics & numerical data; D004353:Drug Evaluation, Preclinical / Q000379:methods / Q000706:statistics & numerical data; D004345:Drug Industry / Q000379:methods / Q000706:statistics & numerical data; D006801:Humans